Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Rashmi

Showing results (151-160 of 11,065) with videos related to

Pageof 1,107
Sort By:
Drug Safety|February 6, 2004
Pharmacogenetic aspects of drug-induced torsade de pointes: potential tool for improving clinical drug development and prescribingRashmi R Shah
British Journal of Clinical Pharmacology|August 14, 2012
Drug-induced QT interval prolongation: does ethnicity of the thorough QT study population matter?Rashmi R Shah
Journal of the Indian Medical Association|January 8, 2005
Psychosomatic illness among patients attending medical outpatient departmentS Kumar, Rashmi
Drug Safety|February 5, 2005
Drugs, QT interval prolongation and ICH E14: the need to get it rightRashmi R Shah
Indian Pediatrics|August 9, 2005
Branding: a harmful practiceSudhir Kumar, Rashmi
Journal of Paediatrics and Child Health|May 10, 2012
Viral bronchiolitis for the clinicianRashmi Ranjan Das
Drug Safety|October 20, 2005
Drugs, QTc interval prolongation and final ICH E14 guideline : an important milestone with challenges aheadRashmi R Shah
Journal of Clinical Pharmacy and Therapeutics|October 13, 2018
Metamizole (dipyrone)-induced agranulocytosis: Does the risk vary according to ethnicity?Rashmi R Shah
Endocrine Practice : Official Journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists|October 6, 2018
MAKING A DIFFERENCE IN ADRENAL FATIGUERashmi S Mullur
Drug Safety|November 27, 2007
Cardiac repolarisation and drug regulation: assessing cardiac safety 10 years after the CPMP guidanceRashmi R Shah
Pageof 1,107

Showing results (151-160 of 11,065) with videos related to

Sort By:
Pageof 1,107
Drug Safety|February 6, 2004
Pharmacogenetic aspects of drug-induced torsade de pointes: potential tool for improving clinical drug development and prescribingRashmi R Shah
British Journal of Clinical Pharmacology|August 14, 2012
Drug-induced QT interval prolongation: does ethnicity of the thorough QT study population matter?Rashmi R Shah
Journal of the Indian Medical Association|January 8, 2005
Psychosomatic illness among patients attending medical outpatient departmentS Kumar, Rashmi
Drug Safety|February 5, 2005
Drugs, QT interval prolongation and ICH E14: the need to get it rightRashmi R Shah
Indian Pediatrics|August 9, 2005
Branding: a harmful practiceSudhir Kumar, Rashmi
Journal of Paediatrics and Child Health|May 10, 2012
Viral bronchiolitis for the clinicianRashmi Ranjan Das
Drug Safety|October 20, 2005
Drugs, QTc interval prolongation and final ICH E14 guideline : an important milestone with challenges aheadRashmi R Shah
Journal of Clinical Pharmacy and Therapeutics|October 13, 2018
Metamizole (dipyrone)-induced agranulocytosis: Does the risk vary according to ethnicity?Rashmi R Shah
Endocrine Practice : Official Journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists|October 6, 2018
MAKING A DIFFERENCE IN ADRENAL FATIGUERashmi S Mullur
Drug Safety|November 27, 2007
Cardiac repolarisation and drug regulation: assessing cardiac safety 10 years after the CPMP guidanceRashmi R Shah
Pageof 1,107